🎉 M&A multiples are live!
Check it out!

Synthetic MR Valuation Multiples

Discover revenue and EBITDA valuation multiples for Synthetic MR and similar public comparables like CurveBeam AI, Australian Clinical Labs, and Cyclopharm.

Synthetic MR Overview

About Synthetic MR

Synthetic MR AB develops software solutions for Magnetic Resonance Imaging that support shorter exam times and deliver more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a license agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.


Founded

2007

HQ

Sweden
Employees

40

Website

syntheticmr.com

Financials

LTM Revenue $5.9M

LTM EBITDA -$1.6M

EV

$13.4M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Synthetic MR Financials

As of September 2025, Synthetic MR reported last 12-month revenue of $5.9M and EBITDA of -$1.6M.

In the same period, Synthetic MR achieved -$2.9M in LTM net income.

See Synthetic MR valuation multiples based on analyst estimates

Synthetic MR P&L

In the most recent fiscal year, Synthetic MR reported revenue of $5.9M and EBITDA of -$0.9M.

Synthetic MR expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Synthetic MR valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $5.9M XXX $5.9M XXX XXX XXX
Gross Profit n/a XXX $6.5M XXX XXX XXX
Gross Margin n/a XXX 111% XXX XXX XXX
EBITDA -$1.6M XXX -$0.9M XXX XXX XXX
EBITDA Margin -27% XXX -16% XXX XXX XXX
EBIT -$2.8M XXX -$2.1M XXX XXX XXX
EBIT Margin -47% XXX -35% XXX XXX XXX
Net Profit -$2.9M XXX -$1.7M XXX XXX XXX
Net Margin -49% XXX -29% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Synthetic MR Stock Performance

Synthetic MR has current market cap of SEK 143M (or $15.0M), and EV of SEK 128M (or $13.4M).

Market Cap Evolution

Synthetic MR Stock Data

As of October 17, 2025, Synthetic MR's stock price is SEK 2 (or $0).

See Synthetic MR trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$13.4M $15.0M XXX XXX XXX XXX $-0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Synthetic MR Valuation Multiples

Synthetic MR's trades at 2.3x EV/Revenue multiple, and -14.3x EV/EBITDA.

See valuation multiples for Synthetic MR and 15K+ public comps

Synthetic MR Financial Valuation Multiples

As of October 17, 2025, Synthetic MR has market cap of $15.0M and EV of $13.4M.

Equity research analysts estimate Synthetic MR's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Synthetic MR has a P/E ratio of -5.2x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $15.0M XXX $15.0M XXX XXX XXX
EV (current) $13.4M XXX $13.4M XXX XXX XXX
EV/Revenue 2.3x XXX 2.3x XXX XXX XXX
EV/EBITDA -8.5x XXX -14.3x XXX XXX XXX
EV/EBIT -4.8x XXX -6.5x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E -5.2x XXX -8.9x XXX XXX XXX
EV/FCF n/a XXX -12.3x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Synthetic MR Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Synthetic MR Margins & Growth Rates

Synthetic MR's last 12 month revenue growth is 18%

Synthetic MR's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.

Synthetic MR's rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Synthetic MR's rule of X is 19% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Synthetic MR and other 15K+ public comps

Synthetic MR Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 18% XXX 11% XXX XXX XXX
EBITDA Margin -27% XXX -16% XXX XXX XXX
EBITDA Growth -64% XXX n/a XXX XXX XXX
Rule of 40 40% XXX 2% XXX XXX XXX
Bessemer Rule of X XXX XXX 19% XXX XXX XXX
Revenue per Employee XXX XXX $0.1M XXX XXX XXX
Opex per Employee XXX XXX $0.2M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 146% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Synthetic MR Public Comps

See public comps and valuation multiples for Medical Imaging & Diagnostics and Healthcare Software comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Clarity Pharmaceuticals XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Cyclopharm XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Synthetic MR M&A and Investment Activity

Synthetic MR acquired  XXX companies to date.

Last acquisition by Synthetic MR was  XXXXXXXX, XXXXX XXXXX XXXXXX . Synthetic MR acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Synthetic MR

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Synthetic MR

When was Synthetic MR founded? Synthetic MR was founded in 2007.
Where is Synthetic MR headquartered? Synthetic MR is headquartered in Sweden.
How many employees does Synthetic MR have? As of today, Synthetic MR has 40 employees.
Is Synthetic MR publicy listed? Yes, Synthetic MR is a public company listed on SAT.
What is the stock symbol of Synthetic MR? Synthetic MR trades under SYNT ticker.
When did Synthetic MR go public? Synthetic MR went public in 2013.
Who are competitors of Synthetic MR? Similar companies to Synthetic MR include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm.
What is the current market cap of Synthetic MR? Synthetic MR's current market cap is $15.0M
What is the current revenue of Synthetic MR? Synthetic MR's last 12 months revenue is $5.9M.
What is the current revenue growth of Synthetic MR? Synthetic MR revenue growth (NTM/LTM) is 18%.
What is the current EV/Revenue multiple of Synthetic MR? Current revenue multiple of Synthetic MR is 2.3x.
Is Synthetic MR profitable? Yes, Synthetic MR is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Synthetic MR? Synthetic MR's last 12 months EBITDA is -$1.6M.
What is Synthetic MR's EBITDA margin? Synthetic MR's last 12 months EBITDA margin is -27%.
What is the current EV/EBITDA multiple of Synthetic MR? Current EBITDA multiple of Synthetic MR is -8.5x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.